(CALM) Cal-Maine Foods - Overview
Stock: Shell Eggs, Cage-Free, Organic, Brown, Free-Range, Pasture-Raised
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 8.42% |
| Yield on Cost 5y | 26.07% |
| Yield CAGR 5y | 299.61% |
| Payout Consistency | 75.5% |
| Payout Ratio | 33.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.8% |
| Relative Tail Risk | -5.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.40 |
| Alpha | -23.88 |
| Character TTM | |
|---|---|
| Beta | 0.324 |
| Beta Downside | -0.019 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.00% |
| CAGR/Max DD | 0.63 |
Description: CALM Cal-Maine Foods January 09, 2026
Cal-Maine Foods, Inc. (NASDAQ: CALM) is the largest U.S. producer and distributor of shell eggs and egg-based products, operating a vertically integrated business that covers production, grading, packaging, marketing, and nationwide distribution. Its portfolio spans conventional eggs and specialty lines-including cage-free, organic, free-range, pasture-raised, and nutritionally enhanced varieties-sold under brands such as Egg-Land’s Best, Land O’ Lakes, Farmhouse Eggs, Sunups, Sunny Meadow, and 4-Grain. The company also offers ready-to-eat items (hard-cooked eggs, egg wraps, protein pancakes, crepes) and ancillary products like feed and by-products, serving grocery chains, club stores, independent supermarkets, food-service distributors, and direct consumers across most U.S. regions and Puerto Rico.
Key industry metrics that shape Cal-Maine’s performance include: (1) **Egg production volume**, which in 2023 averaged ~1.5 billion dozen eggs-a scale that underpins its ~30 % share of the U.S. shell-egg market; (2) **Feed cost elasticity**, where corn and soybean price movements can swing operating margins by 5-10 % given feed accounts for roughly 65 % of total production costs; and (3) **Premium-egg demand growth**, with cage-free and organic segments expanding at ~8-10 % CAGR, driven by consumer health trends and retail commitments to higher-welfare sourcing.
For a deeper, data-driven assessment of CALM’s valuation dynamics and scenario analysis, consider exploring the detailed metrics and forward-looking models available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.15b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.37 > 0.02 and ΔFCF/TA 18.38 > 1.0 |
| NWC/Revenue: 36.45% < 20% (prev 37.73%; Δ -1.29% < -1%) |
| CFO/TA 0.43 > 3% & CFO 1.36b > Net Income 1.15b |
| Net Debt (-369.4m) to EBITDA (1.64b): -0.23 < 3 |
| Current Ratio: 8.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (48.2m) vs 12m ago -1.64% < -2% |
| Gross Margin: 41.92% > 18% (prev 0.33%; Δ 4159 % > 0.5%) |
| Asset Turnover: 149.6% > 50% (prev 123.9%; Δ 25.70% > 0%) |
| Interest Coverage Ratio: 3043 > 6 (EBITDA TTM 1.64b / Interest Expense TTM 506.0k) |
Altman Z'' 10.00
| A: 0.49 (Total Current Assets 1.75b - Total Current Liabilities 218.8m) / Total Assets 3.14b |
| B: 0.88 (Retained Earnings 2.77b / Total Assets 3.14b) |
| C: 0.55 (EBIT TTM 1.54b / Avg Total Assets 2.82b) |
| D: 6.21 (Book Value of Equity 2.77b / Total Liabilities 446.3m) |
| Altman-Z'' Score: 16.26 = AAA |
Beneish M -3.06
| DSRI: 0.60 (Receivables 262.4m/317.8m, Revenue 4.21b/3.08b) |
| GMI: 0.78 (GM 41.92% / 32.69%) |
| AQI: 1.51 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 1.37 (Revenue 4.21b / 3.08b) |
| TATA: -0.07 (NI 1.15b - CFO 1.36b) / TA 3.14b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of CALM shares?
Over the past week, the price has changed by -1.20%, over one month by +5.27%, over three months by -5.35% and over the past year by -17.58%.
Is CALM a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CALM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.8 | 6.3% |
| Analysts Target Price | 87.8 | 6.3% |
| ValueRay Target Price | 124 | 50.2% |
CALM Fundamental Data Overview February 02, 2026
P/S = 0.9447
P/B = 1.479
P/EG = 0.75
Revenue TTM = 4.21b USD
EBIT TTM = 1.54b USD
EBITDA TTM = 1.64b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -369.4m USD (from netDebt column, last quarter)
Enterprise Value = 2.84b USD (3.98b + (null Debt) - CCE 1.14b)
Interest Coverage Ratio = 3043 (Ebit TTM 1.54b / Interest Expense TTM 506.0k)
EV/FCF = 2.42x (Enterprise Value 2.84b / FCF TTM 1.17b)
FCF Yield = 41.27% (FCF TTM 1.17b / Enterprise Value 2.84b)
FCF Margin = 27.83% (FCF TTM 1.17b / Revenue TTM 4.21b)
Net Margin = 27.37% (Net Income TTM 1.15b / Revenue TTM 4.21b)
Gross Margin = 41.92% ((Revenue TTM 4.21b - Cost of Revenue TTM 2.45b) / Revenue TTM)
Gross Margin QoQ = 26.95% (prev 33.74%)
Tobins Q-Ratio = 0.90 (Enterprise Value 2.84b / Total Assets 3.14b)
Interest Expense / Debt = unknown (Interest Expense 201.0k / Debt none)
Taxrate = 24.36% (33.2m / 136.1m)
NOPAT = 1.16b (EBIT 1.54b * (1 - 24.36%))
Current Ratio = 8.02 (Total Current Assets 1.75b / Total Current Liabilities 218.8m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -0.23 (Net Debt -369.4m / EBITDA 1.64b)
Debt / FCF = -0.32 (Net Debt -369.4m / FCF TTM 1.17b)
Total Stockholder Equity = 2.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 40.93% (Net Income 1.15b / Total Assets 3.14b)
RoE = 44.65% (Net Income TTM 1.15b / Total Stockholder Equity 2.58b)
RoCE = 52.64% (EBIT 1.54b / Capital Employed (Total Assets 3.14b - Current Liab 218.8m))
RoIC = 45.09% (NOPAT 1.16b / Invested Capital 2.58b)
WACC = 7.11% (E(3.98b)/V(3.98b) * Re(7.11%) + (debt-free company))
Discount Rate = 7.11% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.72%
[DCF Debug] Terminal Value 84.21% ; FCFF base≈892.0m ; Y1≈1.10b ; Y5≈1.87b
Fair Price DCF = 817.3 (EV 38.58b - Net Debt -369.4m = Equity 38.95b / Shares 47.7m; r=7.11% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 26.74 | EPS CAGR: 29.41% | SUE: 0.06 | # QB: 0
Revenue Correlation: 57.69 | Revenue CAGR: 13.57% | SUE: -0.53 | # QB: 0
EPS current Year (2026-05-31): EPS=7.79 | Chg30d=-2.260 | Revisions Net=-1 | Growth EPS=-68.9% | Growth Revenue=-29.1%
EPS next Year (2027-05-31): EPS=3.88 | Chg30d=-1.790 | Revisions Net=-1 | Growth EPS=-50.2% | Growth Revenue=-8.3%